Free Trial

Sonnet BioTherapeutics (SONN) Insider Trading & Ownership

Sonnet BioTherapeutics logo
$4.32 +0.18 (+4.22%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$4.49 +0.17 (+3.82%)
As of 07/3/2025 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sonnet BioTherapeutics (NASDAQ:SONN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.00%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$105.30K
Number Of
Insiders Selling
(Last 3 Years)
0
Get SONN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sonnet BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SONN Insider Buying and Selling by Quarter

Sonnet BioTherapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2023Susan DexterInsiderBuy56$123.20$6,899.20  
5/30/2023Albert D DyrnessDirectorBuy132$82.72$10,919.04  
5/17/2023Nailesh BhattDirectorBuy142$40.48$5,748.16  
5/15/2023Pankaj MohanCEOBuy2,111$38.72$81,737.92  
(Data available from 1/1/2013 forward)

SONN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Sonnet BioTherapeutics includes Albert D Dyrness, Nailesh Bhatt, Pankaj Mohan, and Susan Dexter. Learn more on insiders at SONN.

2.00% of Sonnet BioTherapeutics stock is owned by insiders. Learn more on SONN's insider holdings.



This page (NASDAQ:SONN) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners